News Phoenix Life Sciences International Limited

Equities

PLSI

US71910Q1022

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ArCare Holdings Sdn Bhd entered into letter of intent to acquire Phoenix Life Sciences International Limited.	24/21/24	CI
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Non-Reliance on Previous Financials, Audits or Interim Review, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	21/20/21	AQ
Phoenix Life Sciences International Limited cancelled the transaction announced on April 30, 2019	30/20/30	CI
Phoenix Life Sciences International Limited Reports Earnings Results for the Full Year Ended February 28, 2019	10/20/10	CI
Phoenix Life Sciences International Limited Announces Management Changes	30/19/30	CI
Phoenix Life Sciences International Limited Announces Resignation of Michael Gobel from His Role as Director	09/19/09	CI
Phoenix Life Sciences International Limited Announces Management Changes	11/19/11	CI
Phoenix Life Sciences International Limited Announces Management Changes	28/19/28	CI
Phoenix Life Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License	04/19/04	GL
Phoenix Life Sciences International Limited Signs Exclusive Agreement with Vanuatu Government for 25-Year Diabetes Management Program and Global Medical Cannabis Export License	04/19/04	CI
Phoenix Life Sciences International Announces Presentation at MjMicro Cap Conference in Preparation to Uplist to the OTCQB Market	29/19/29	GL
Phoenix Life Sciences International Limited Names Maturine Carlot-Tary as Director of Health and Nutrition	17/19/17	CI
Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference	01/19/01	GL
Phoenix Life Sciences International Limited announced that it expects to receive $40 million in funding	30/19/30	CI
Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018	26/19/26	GL
Phoenix Life Sciences International Limited Appoints John Taleo as Global Head of Security	16/19/16	CI
Phoenix Life Sciences International Announces Giving Pledge Commitment and Launch of The Global Health Initiative with Kylie OBrien Ph.D.	11/19/11	GL
Phoenix Life Sciences International Limited announced that it has received $0.879685 million in funding	11/19/11	CI
Phoenix Life Sciences International Appoints Tekon Timothy Tumukon as Company's Head of Biosecurity Services	08/19/08	GL
Phoenix Life Sciences International Limited Appoints Tekon Timothy Tumukon as Head of Biosecurity Services	08/19/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Phoenix Life Sciences International Limited

Equities

PLSI

US71910Q1022

Summary

Filters